Couple Walking
/clinics/urology/ Welcome

Cancer Treatment

Contact Us


Living with a diagnosis of cancer can be a stressful and fearful time. The University of Toledo Department of Urology focuses on maintaining a high quality of life for our patients while utilizing the most up-to-date technology to cure their disease. Let us be your guide as you travel down the road of being a survivor.

Prostate Cancer

Carcinoma of the prostate is the most common cancer that afflicts men. Historically, men would present with advanced disease; however with advances in screening techniques, we are now diagnosing the disease at earlier and curable stages. Recently, PSA screening has come under fire by the U.S. Preventive Services Task Force; however, the American Urologic Association, as well as our specialists, still support and promote PSA screening for this potentially fatal disease.

The Department of Urology at the University of Toledo is the first and only center in the region routinely using MRI as part of the diagnostic strategy for prostate cancer. Our pioneering work has saved countless men unnecessary prostate biopsies and has allowed us to focus treatment on those who need it most. 

Our fellowship-trained specialists at The University of Toledo Department of Urology offer the latest, cutting edge in surgical, radiation and medical therapy for men diagnosed with prostate cancer. Our surgeons are fellowship trained in Robotics and other minimally invasive therapies for the cure of prostate cancer to help get you back to living your life with less pain and scarring. To further discuss how to cure your prostate cancer, call today to schedule your appointment.

Bladder Cancer

The most common symptom for bladder cancer is blood in the urine, or gross hematuria. If you have experienced blood in your urine, you should call one of our specialists immediately for consultation.

If you have been diagnosed with bladder cancer, treatment of The University of Toledo Department of Urology is the right choice for you. We take a stepwise, multimodal approach for maximally aggressive therapy with minimal invasiveness. We offer all forms of treatment, including bladder preservation therapy. If surgery is your best option, we have fellowship-trained specialists who use the da Vinci robotics system to minimize your pain, blood loss and scarring. We are also trained in all forms of bladder reconstruction, fitting your new bladder to the quality of life to which you are accustomed. Call today to discuss your care with one of our specialists.

Kidney Cancer

Most kidney cancers in this day and age are incidentally diagnosed as small growths on either kidney. We now know that removal of the mass, and not the entire kidney, benefits patients by curing their cancer while preserving as much normal, healthy kidney tissue as possible. Our fellowship-trained physicians utilize the most recent updates in minimally invasive technologies, such as laparoscopy, robotics and percutaneous ablation to cure this deadly cancer and get you back on your feet with minimal pain and scarring. Call today to make an appointment.

Testicular Cancer

While testicular cancer is very rare, it is still one of the most common solid tumors diagnosed in men younger than the age of 35. Most men diagnose the disease by self exam when they feel a lump or bump on their testicle.

For those diagnosed with testicular cancer, the specialists at The University of Toledo take a multispecialty approach to treating and curing their disease. Our medical, radiation and urologic oncologists all work together to aggressively treat and cure the disease while getting you back to the active lifestyle to which you are accustomed. If you have felt a mass on your testicle or have the diagnosis of testicular cancer, call one of our specialists today for an appointment.

Schedule an Appointment

Call today and schedule your appointment with our team.


Directions and Parking

  • Health Science Campus
  • UT Medical Center
  • 3000 Arlington Ave.

Valet parking available

View Map
Last Updated: 6/27/22